PITCH for COPD
Beyond Blame: Rethinking Interventions for Smokers and Early COPD
A case for compassion-led, evidence-based digital health intervention in COPD stigma and tobacco use disorder
“I have really been trying to quit, doctor, but it is not easy.” At least once in every respiratory clinic we hear such an uncomfortable, apologetic response. These patients have been stigmatised due to their disease — and current approaches are making it worse.
The Problem
COPD meets all six established dimensions of a stigmatised condition: it is unconcealable, progressive, disruptive to social interaction, aesthetically stigmatised, framed as self-inflicted, and perceived as a risk to others. Stigma leads to impaired mental wellbeing, delayed help-seeking, and poorer health outcomes.
The Fallacy
COPD is multifactorial — one in five patients have never smoked. Nicotine addiction carries substantial heritability, the tobacco industry spent decades and billions on targeted marketing, and the DSM-5 classifies tobacco use disorder as a medical condition. Blame is both scientifically inaccurate and clinically harmful.
The Opportunity
Patients go months between clinic visits with no digital touchpoints to detect worsening symptoms, support cessation attempts, or intervene before a crisis. This is a missed Just-in-Time Adaptive Intervention (JITAI) opportunity. Digital health interventions are uniquely positioned to close this gap — but only if they first abandon stigma-reinforcing framings.
The Pitch
Five pillars of a better approach: destigmatise the condition first; implement early screening and spirometry tools; treat cessation as the medical intervention it is; enable continuous remote symptom monitoring; and build peer support networks to buffer stigma and improve adherence.
The Stigma Problem
COPD uniquely satisfies all six dimensions of Scrambler’s stigma framework (1972; Scrambler & Hopkins, 1986).
Unconcealable
Breathlessness, coughing, and visible oxygen equipment cannot be hidden in public or social settings.
Progressive
The condition visibly worsens over time, continually reinforcing its presence to others and to the patient themselves.
Disruptive
Coughing fits and activity limitations interrupt conversations and social participation in ways others notice.
Aesthetically Stigmatised
Coughing and breathlessness trigger instinctive discomfort, fear, or disgust in observers unfamiliar with the condition.
“Self-Inflicted”
Patients are routinely blamed for their own condition — an oversimplification that ignores genetics, marketing, and the multifactorial origin of COPD.
Perceived as Harmful to Others
Coughing is readily confused with contagion risk, particularly in post-pandemic social contexts.
Stigma leads to delayed help-seeking, non-disclosure of symptoms, disengagement from care, and poorer medication adherence. When patients feel blamed by healthcare providers, they disengage from the system entirely.
Unintended Consequence of Public Health Campaigns
Anti-tobacco campaigns, while well-intentioned, place the full moral and causal burden of COPD on smoking. This unintentionally deepens stigma. Patients who feel blamed — by society and by the healthcare system — are less likely to present early, less likely to disclose worsening symptoms, and less likely to adhere to treatment.
The Fallacy of Self-Blame
Three structural arguments that challenge the “self-inflicted” framing of COPD.
COPD is multifactorial. Biomass fuel exposure, occupational dust, air pollution, lung development in early life, and genetic factors all contribute. Framing the condition as caused by smoking alone is both scientifically inaccurate and clinically harmful.
Over decades, the tobacco industry deployed billions in deliberate, targeted advertising designed to build dependency before the harms of smoking were publicly understood. Blaming patients ignores the commercial and social context in which addiction developed.
Nicotine addiction has substantial heritability. Tobacco use disorder is formally classified in the DSM-5 as a medical condition — not a personal failing. Telling patients to “just quit” without pharmacological or digital support reflects a fundamental misunderstanding of the condition being treated.
Stigma is a social construct. It is also a modifiable risk factor. If clinicians, campaigns, and care systems reinforce the “self-inflicted” framing, they become part of the mechanism that worsens outcomes — and that is something we can choose to change.
Why Current Approaches Fall Short
Four structural failures in how COPD is currently identified, framed, and supported.
Late Detection
Most patients present only after significant, irreversible lung damage has already occurred. Spirometry is underused in primary care, and early symptoms are dismissed, normalised, or attributed to other causes. There is no systematic early-identification pathway for high-risk individuals.
Shame-Driven Disengagement
Patients who feel blamed by healthcare providers disengage from care. Stigma leads to delayed help-seeking, non-disclosure of worsening symptoms, and poor medication adherence. The shame cycle actively undermines the effectiveness of every other intervention.
Cessation Support is Inadequate
Brief advice alone has very low success rates for tobacco cessation. Telling patients to “just quit” without acknowledging the DSM-5 classification of tobacco use disorder, or without offering pharmacological and digital support, reflects an inadequate treatment standard.
No Digital Touchpoints Between Visits
Patients go months between clinic appointments with no system to detect worsening symptoms, offer real-time behavioural support, or intervene before an exacerbation. This is the defining missed opportunity for a Just-in-Time Adaptive Intervention (JITAI).
Where Digital Health Fits
Each of these four gaps has a credible digital health response. Symptom trackers and wearables enable early detection between visits. JITAI systems can trigger cessation support in moments of high craving or stress. App-based psychoeducation can reframe COPD away from blame. Community platforms can connect patients to peer networks that buffer stigma. The technology exists — what is missing is a framework that begins with compassion rather than blame.
A Better Way
Five pillars of compassion-led, JITAI-enabled intervention for smokers and early COPD.
-
01
Destigmatise First
Reframe COPD as the multifactorial condition it is, in all patient-facing communication. Train clinicians explicitly in non-blame language. Work with public health campaigns to move from individual culpability to shared environmental and systemic framing. Stigma reduction is not a soft outcome — it is a prerequisite for every other intervention to function.
-
02
Early Screening and Spirometry Tools
Digital intake tools, symptom checkers, and app-based spirometry guidance embedded in primary care workflows can identify at-risk individuals before irreversible damage occurs. Proactive screening in smokers and occupationally-exposed populations should be systematic, not opportunistic.
-
03
Cessation as Medical Treatment
Combine evidence-based pharmacotherapy (varenicline, NRT, bupropion) with app-based JITAI support that triggers cessation encouragement, distraction, and coping prompts in moments of high craving or identified stress. Cessation must be treated with the same clinical seriousness as managing any other DSM-5 condition.
-
04
Continuous Remote Monitoring
Wearables and mobile applications tracking respiratory symptoms, activity, and sleep between clinic visits enable proactive clinical outreach before exacerbations occur. Closed-loop systems that flag deterioration can shift care from reactive to preventive — and create the regular touchpoints that are currently absent.
-
05
Peer and Community Support
Connect patients with peer networks of others living with COPD or managing tobacco use disorder. Social support is an established buffer against stigma and an independent predictor of improved adherence and outcomes. Digital platforms and moderated communities can scale this in ways clinic-based support cannot.
Interventions must treat tobacco use disorder as the medical condition it is — and meet patients with dignity, not blame. A system that begins with compassion is not only more ethical; the evidence suggests it is also more effective.
■ Disease & Condition ■ Stigma Theory ■ Clinical & Regulatory ■ Digital Intervention
Disease & Condition
Stigma Theory
Clinical & Regulatory
Digital Intervention
Primary Source
This pitch brief draws directly from the following peer-reviewed commentary.
Stigma: an unmet public health priority in COPD
Correspondence COPD · Stigma Lancet Respir MedMathioudakis AG, Ananth S, Vestbo J. Stigma: an unmet public health priority in COPD. Lancet Respir Med. 2021 Sep;9(9):955–956. doi: 10.1016/S2213-2600(21)00316-7. PMID: 34197813. Published online June 28, 2021. © 2021 Elsevier Ltd.
Author Affiliations
Alexander G Mathioudakis and Jørgen Vestbo: Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester / The North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, UK. Sachin Ananth: West Hertfordshire Hospital NHS Trust, Watford, UK.